by shannon@kinsdesign.co | Jan 13, 2026 | News
Ruizhi Wang, CEO and Founder of Abselion, has been included in a Technology Networks feature exploring how collaboration continues to drive innovation across the life sciences. The article gathers expert perspectives on the role of collaboration in accelerating...
by shannon@kinsdesign.co | Jan 8, 2026 | News
Abselion’s CEO and Founder, Ruizhi Wang, has been featured in a multi-contributor article published by Technology Networks, sharing industry perspectives on how laboratory environments are evolving. The article brings together voices from across the life sciences to...
by shannon@kinsdesign.co | Dec 15, 2025 | News
BioCompare’s 2026 outlook brings together perspectives from across the life sciences, including insights from Abselion’s Founder & CEO, Dr. Ruizhi Wang, on the evolving needs of biologics discovery and development. BioCompare has published “A Look Ahead:...
by shannon@kinsdesign.co | Nov 28, 2025 | News
News-Medical publishes interview with Abselion on His-tagged protein analysisl News-Medical has published a new interview with Abselion Founder & CEO Dr Ruizhi Wang, discussing how researchers are using the Amperia™ platform to support reliable His-tagged protein...
by shannon@kinsdesign.co | Oct 30, 2025 | News
Technology Networks features Abselion in discussion on advancing AAV quantification Technology Networks has published a new interview with Abselion Founder & CEO Dr Ruizhi Wang, exploring the challenges of AAV capsid quantification and the need for more...
by shannon@kinsdesign.co | Oct 7, 2025 | News
Biocompare highlights Abselion among industry voices shaping mAb characterization In Biocompare’s editorial The Evolving Landscape of mAb Characterization, leaders from across the biologics field — including Abselion CEO Dr Ruizhi Wang — discuss how emerging...
